Fresenius, DE0005785604

Fresenius Stock - chart picture and technical levels on Thursday

18.06.2026 - 16:39:38 | ad-hoc-news.de

Fresenius starts Thursday without fresh ad-hoc news or major analyst calls, but the chart and key technical levels still matter for investors. This article looks at the current setup around the 200-day moving average and recent price range.

Fresenius, DE0005785604
Fresenius, DE0005785604

Edited by ad hoc news Chart & Technicals Desk. Verified prior to publication on 06/18/2026, 16:38 CET. Details in the imprint.

Fresenius (DE0005785604) begins Thursday trading without a new company announcement or fresh analyst rating change that would clearly set the tone. Instead, the spotlight is on the technical picture around key support and resistance levels on the chart.

Go deeper

All news and key data on Fresenius stock

Current reports, background and prices on Fresenius stock can be found in the dedicated topic area on ad-hoc-news.de and on the company’s investor-relations pages.

Chart picture on Thursday

There is no new ad-hoc or major strategic news from Fresenius on Thursday, and no fresh broker study that would serve as a clear immediate driver for the stock. Instead, traders focus on the technical configuration after the recent consolidation.

On balance, the shares have been trading in a broad sideways range for several weeks, with local support formed by recent swing lows and resistance defined by earlier reaction highs. This range trading keeps short-term technical indicators in a neutral to slightly constructive zone.

Key technical levels and 200-day line

The 200-day moving average often acts as a medium-term orientation mark for many market participants, including for large German healthcare names such as Fresenius. The stock currently orbits this longer-term trend line, signaling a still undecided medium-term picture.

Below that, short-term support is typically derived from recent lows of the past few weeks, while resistance comes from former highs and volume clusters that previously capped the price. Against this backdrop, many chart watchers pay close attention to any convincing breakout above resistance or break below support.

How Fresenius makes its money

Fresenius is a diversified healthcare group that generates revenue mainly from hospital operations, intravenous drugs and clinical nutrition, as well as project and service business for clinics and other healthcare facilities. Key operating units include Helios hospitals, Kabi pharmaceuticals and Vamed services.

Where the stock trades today

The shares of Fresenius (DE0005785604) trade on Xetra at EUR 30.00 as of 06/18/2026, 16:30 CET.

Key facts on Fresenius stock

  • Company: Fresenius SE & Co. KGaA
  • ISIN: DE0005785604
  • WKN: 578560
  • Ticker: FRE
  • Venue: Xetra
  • Price (as of 06/18/2026, 16:30 CET): 30.00 EUR
  • Market cap: 17,000,000,000 EUR (as of 06/18/2026)
  • Sector / Industry: Health Care / Health Care Providers & Services
  • Index membership: DAX
  • Next earnings date: not officially scheduled

More on Fresenius stock on social media

This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.

en | DE0005785604 | FRESENIUS | boerse | 69573746 | bgmi